Roche Sars-CoV-2 Antigen Test (25 Test/Box)
$0.00
In addition to laboratory PCR tests, antigen tests can be offered as rapid testing in bedside settings. The SARS-CoV-2 Rapid Antigen Test is a rapid chromatographic immunochemistry test for the qualitative detection of specific SARS‑CoV‑2 antigens found in the human nasopharynx.
This test was developed to detect the SARS‑CoV‑2 virus antigen in individuals suspected of contracting COVID‑19. This product is for professional use in the laboratory and bedside environment only. Similar to laboratory instruments, it detects a SARS-CoV-2 antigen, nucleoprotein. Thus, it can be used to assess whether a person is infected with SARS-CoV-2 by providing a qualitative result by displaying colored bands indicating the presence of SARS-CoV-2 antigens.
The SARS-CoV-2 Rapid Antigen Test prevents further spread of the virus by supporting rapid decision-making, for example, whether or not patients should be quarantined. In addition, it allows screening of individuals who have been confirmed to have come into contact with a person infected with SARS-CoV-2, or individuals at risk of exposure, such as healthcare workers.
The SARS-CoV-2 Rapid Antigen Test enables point-of-care testing and increases the reach and number of direct virus testing, allowing the test to be delivered to previously inaccessible locations. Rapid point-of-care testing may be the only viable option when laboratory tests are not sufficiently accessible. In addition, the SARS-CoV-2 Rapid Antigen Test is a device-free test, allowing testing in rural areas where infrastructure is inadequate.
SARS-CoV-2 Rapid Antigen Test overview:
Fast results in 15-30 minutes - no follow-up appointment needed to discuss the result
Easy to use that does not require special training
No device required
It enables point-of-care testing and provides access to testing in areas where laboratory testing is inaccessible.In addition to laboratory PCR tests, antigen tests can be offered as rapid testing in bedside settings. The SARS-CoV-2 Rapid Antigen Test is a rapid chromatographic immunochemistry test for the qualitative detection of specific SARS‑CoV‑2 antigens found in the human nasopharynx.
This test was developed to detect the SARS‑CoV‑2 virus antigen in individuals suspected of contracting COVID‑19. This product is for professional use in the laboratory and bedside environment only. Similar to laboratory instruments, it detects a SARS-CoV-2 antigen, nucleoprotein. Thus, it can be used to assess whether a person is infected with SARS-CoV-2 by providing a qualitative result by displaying colored bands indicating the presence of SARS-CoV-2 antigens.
The SARS-CoV-2 Rapid Antigen Test prevents further spread of the virus by supporting rapid decision-making, for example, whether or not patients should be quarantined. In addition, it allows screening of individuals who have been confirmed to have come into contact with a person infected with SARS-CoV-2, or individuals at risk of exposure, such as healthcare workers.
The SARS-CoV-2 Rapid Antigen Test enables point-of-care testing and increases the reach and number of direct virus testing, allowing the test to be delivered to previously inaccessible locations. Rapid point-of-care testing may be the only viable option when laboratory tests are not sufficiently accessible. In addition, the SARS-CoV-2 Rapid Antigen Test is a device-free test, allowing testing in rural areas where infrastructure is inadequate.
SARS-CoV-2 Rapid Antigen Test overview:
Fast results in 15-30 minutes - no follow-up appointment needed to discuss the result
Easy to use that does not require special training
No device required
It enables point-of-care testing and provides access to testing in areas where laboratory testing is inaccessible.In addition to laboratory PCR tests, antigen tests can be offered as rapid testing in bedside settings. The SARS-CoV-2 Rapid Antigen Test is a rapid chromatographic immunochemistry test for the qualitative detection of specific SARS‑CoV‑2 antigens found in the human nasopharynx.
This test was developed to detect the SARS‑CoV‑2 virus antigen in individuals suspected of contracting COVID‑19. This product is for professional use in the laboratory and bedside environment only. Similar to laboratory instruments, it detects a SARS-CoV-2 antigen, nucleoprotein. Thus, it can be used to assess whether a person is infected with SARS-CoV-2 by providing a qualitative result by displaying colored bands indicating the presence of SARS-CoV-2 antigens.
The SARS-CoV-2 Rapid Antigen Test prevents further spread of the virus by supporting rapid decision-making, for example, whether or not patients should be quarantined. In addition, it allows screening of individuals who have been confirmed to have come into contact with a person infected with SARS-CoV-2, or individuals at risk of exposure, such as healthcare workers.
The SARS-CoV-2 Rapid Antigen Test enables point-of-care testing and increases the reach and number of direct virus testing, allowing the test to be delivered to previously inaccessible locations. Rapid point-of-care testing may be the only viable option when laboratory tests are not sufficiently accessible. In addition, the SARS-CoV-2 Rapid Antigen Test is a device-free test, allowing testing in rural areas where infrastructure is inadequate.
SARS-CoV-2 Rapid Antigen Test overview:
Fast results in 15-30 minutes - no follow-up appointment needed to discuss the result
Easy to use that does not require special training
No device required
It enables point-of-care testing and provides access to testing in areas where laboratory testing is inaccessible.